Chemours appoints Denise Dignam as President and CEO, replacing Mark Newman

Chemours Co

Denise Dignam named President and CEO effective March 22, 2024; she was interim CEO since February 2024.
Mark Newman resigned as officer and director; separation agreement grants extended stock option exercise period but no severance.
Dignam's compensation: $975k base salary, 120% target bonus, $4.355M LTI award.
Matthew Abbott continues as interim CFO; search for permanent CFO underway.
Diane Iuliano Picho named interim President, Titanium Technologies.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Newman

President and Chief Executive Officer

CC · Chemours Co

Effective: 2024-03-22
Successor: Denise Dignam
Filed: March 25, 2024, 7:59 PM ET

Mark Newman, who resigned from his officer and director positions with the Company, also effective as of March 22, 2024.

Appointed

Denise Dignam

President and Chief Executive Officer

CC · Chemours Co

Effective: 2024-03-22
Filed: March 25, 2024, 7:59 PM ET

The Board of Directors (the “Board”) of The Chemours Company (the “Company”) has named Denise Dignam, formerly Interim Chief Executive Officer, as President and Chief Executive Officer and as a member of the Board, effective as of March 22, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark Newman resigned as President and Chief Executive Officer at Chemours Co.

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

Mark Newman, who resigned from his officer and director positions with the Company, also effective as of March 22, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Denise Dignam was named as President and Chief Executive Officer at Chemours Co.

Action: named
Role: President and Chief Executive Officer

Exact text from the filing

The Board of Directors (the “Board”) of The Chemours Company (the “Company”) has named Denise Dignam, formerly Interim Chief Executive Officer, as President and Chief Executive Officer and as a member of the Board, effective as of March 22, 2024.

View on SEC.gov

Chemours Co filing history →

Source: SEC EDGAR

accession 0001193125-24-075860

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.